Nafamostat mesylate (NM), a synthetic serine protease inhibitor first placed on the market by Japan Tobacco in 1986, has been approved to treat inflammatory-related diseases, such as pancreatitis.
What we offered is the high quality Nafamostat mesylate API with high purity and low impurities. For more details, please contact us freely.
Product name：Nafamostat Mesylate
Synonyms: 4-((aminoiminomethyl)amino)-benzoicaci6-(aminoiminomethyl)-2-naphthalenyl;6-carbaMiMidoylnaphthalen-2-yl4-guanidinobenzoatediMethanesulfonate;[amino-[6-[[4-(diaminomethyleneazaniumyl)phenyl]-oxomethoxy]-2-naphthyl]methylene]ammonium;[amino-[6-[4-(diaminomethyleneazaniumyl)benzoyl]oxy-2-naphthyl]methylene]ammonium;[amino-[6-[4-(diaminomethylideneazaniumyl)benzoyl]oxynaphthalen-2-yl]methylidene]azanium;[amino-[6-[4-(diaminomethylideneazaniumyl)phenyl]carbonyloxynaphthalen-2-yl]methylidene]azanium;Nafamostatmesylate,>=98%;5-methyl-1-{6-[(7-oxo-7h-furo[3,2-g]chromen-9-yl)oxy]hexyl}pyrimidine-2,4(1h,3h)-dione
CAS No.: 82956-11-4
Molecular Structure:
Molecular Formula: C19H17N5O2·2(CH4O3S); C21H25N5O8S2
Molecular Weight: 539.58
| Item | Specification |
| Appearance | White Crystalline Powder |
| Solubility | It is freely soluble in formic acid, soluble in water, and practically insoluble in ethanol |
| Identification | UV Identification: UV spectrum should be corresponding to the reference |
| pH | 4.7-5.7 |
| Clarity and color of Solution | Clear; colorless |
| Loss on Drying | ≤0.5% |
| Residue on ignition | ≤0.1% |
| Heavy Metal | ≤10ppm |
| Related Substances | Single impurities≤0.1% Total impurities≤0.5% |
| Assay | 99.0-101.0% |